US 11572367
Antiviral heterocyclic compounds
granted A61KA61K31/4375A61K31/443
Quick answer
US patent 11572367 (Antiviral heterocyclic compounds) held by Enanta Pharmaceuticals, Inc. expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/4375, A61K31/443, A61K31/4709, A61K31/496